Novartis scoops up UK biotech Myricx in $1.5 billion cancer push

Novartis AG NVS has agreed to acquire privately held U.K. biotechnology company Myricx Bio in a deal valued at up to $1.5 ...
The Manila Times

PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset

PharmAla Biotech Holdings Inc. (CSE: MDMA)(OTCQB: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class ...
ZAWYA

Bateen World Academy continues to score above IB global averages with class of 2026 achieving outstanding results

Graduates earn places at world-leading universities across the UK, US, Europe, Australia, Hong Kong and the UAE Results ...
The Manila Times

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

Adds potential first-in-class,N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...
VietNamNet

Vietnam names 11 national exam toppers for 2026

Vietnam's 2026 high school graduation exam produced 11 national toppers and 47 runners-up across the country's five ...
Pharmabiz

US FDA grants breakthrough therapy designation for INTENT Biologics’ PEP Biologic to treat diabetic foot ulcers

US FDA grants breakthrough therapy designation for INTENT Biologics’ PEP Biologic to treat diabetic foot ulcers: Rochester, Minnesota Friday, July 3, 2026, 09:00 Hrs [IST] INTEN ...
The Moultrie Observer

Georgia South Graduate Medical Education celebrates 10 years of physician training during annual resident welcome

Georgia South Graduate Medical Education celebrated a decade of physician training and welcomed its newest class of residents ...
Rutland Herald

Permeasis Therapeutics and The Ohio State University Publish Foundational Research on Intracellular Delivery Technology in ACS Chemical Biology

Permeasis Therapeutics (“Permeasis”), a biotechnology company developing intracellular biologics enabled by its proprietary Membrane Translocation Domain (MTD) platform announced the publication of ...

The circuit that lets your brain think and see

Nuttida Rungratsameetaweemana is challenging a story neuroscience has told for decades. According to the conventional account, our eyes collect raw information and relay it through a series of nerves ...

INTENT Biologics Receives FDA Breakthrough Therapy Designation for PEP Biologic™ for its Phase 3 Ready Flagship Indication

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...
India Today

BTech or BSc? Here's how to choose the right undergraduate degree after Class 12

Confused between BTech and BSc? Understand the differences in eligibility, curriculum, career scope, higher studies and salaries to make the right choice after Class 12.
Pharmabiz

Talawar Therapeutics and JATT II enter definitive business combination agreement to create publicly listed biotechnology company

Talawar Therapeutics and JATT II enter definitive business combination agreement to create publicly listed biotechnology company: New York Wednesday, July 1, 2026, 16:00 Hrs [IST] ...